Enanta Pharmaceuticals
ENTA • NASDAQ
Enanta Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jay R. Luly, with a market cap of $353.5M.
Market Cap$353.5M
Employees145.0
CEOJay R. Luly
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ2 2026
Financials
Enanta Pharmaceuticals FAQ
Common questions about Enanta Pharmaceuticals
Enanta Pharmaceuticals is scheduled to report earnings for Q2 2026 on May 11, 2026. Analysts estimate revenue of $17.1M.
Enanta Pharmaceuticals has approximately 145 employees.